AbelZeta Pharma is a global cell therapy leader focused on discovering, developing and manufacturing therapeutics to address unmet medical needs across hematologic malignancies,
inflammatory and immunological diseases and solid tumors.
Partners: AstraZeneca, Janssen (J&J), Novartis
Investors: HSG, Yunfeng Capital, GIC, TF Capital, CICC Capital, Sailing Capital, Dangdai Group, AstraZeneca-CICC Fund
- 170,000+ different files
- 670+ separate archives with experiments on various candidates
- All studies: CAR032, CAR39, CAR66, CAR168, TIL, CD, Tcell, etc.
There are a huge number of files and studies, all of which are confidential and valuable for competitive research.